301
Views
5
CrossRef citations to date
0
Altmetric
Research Article

The effects of topical everolimus and sunitinib on corneal neovascularization

, , , &
Pages 97-103 | Received 06 Feb 2015, Accepted 22 Mar 2015, Published online: 13 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mimbay Yaşar, Harun Çakmak, Sema Dündar, Seda Örenay Boyacıoğlu, Metin Çalışkan & Kemal Ergin. (2020) The role of microRNAs in corneal neovascularization and its relation to VEGF. Cutaneous and Ocular Toxicology 39:4, pages 341-347.
Read now
Zhan Tang, Lina Yin, Yawen Zhang, Wenying Yu, Qiao Wang & Zhajun Zhan. (2019) Preparation and study of two kinds of ophthalmic nano-preparations of everolimus. Drug Delivery 26:1, pages 1235-1242.
Read now

Articles from other publishers (3)

Zachary Barry, Bomina Park & Timothy W. Corson. (2020) Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization. Molecules 25:15, pages 3468.
Crossref
Jin Young Yang, Sanjar Batirovich Madrakhimov, Dong Hyuck Ahn, Hun Soo Chang, Sang Joon Jung, Seung Kwan Nah, Ha Yan Park & Tae Kwann Park. (2019) mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV. Cell Communication and Signaling 17:1.
Crossref
Chengda Ren, Hui Shi, Juanjuan Jiang, Qingyu Liu, Yaru Du, Mengmei He, Wenting Cai, Qingquan Wei & Jing Yu. (2017) The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats. Journal of Ophthalmology 2017, pages 1-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.